Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells.
about
Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasisInhibition of cancer cell invasion and metastasis by genisteinGlobal characterization of signalling networks associated with tamoxifen resistance in breast cancer.SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatmentBone Targeted Therapies for Bone Metastasis in Breast CancerYes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway.Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.Focal adhesion kinase: a promising target for anticancer therapy.Targeting epidermal growth factor receptor and SRC pathways in head and neck cancerAnti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cellsTargeting Src in breast cancer.Increased levels of active c-Src distinguish invasive from in situ lobular lesions.Repetitive deformation activates Src-independent FAK-dependent ERK motogenic signals in human Caco-2 intestinal epithelial cells.The dual kinase complex FAK-Src as a promising therapeutic target in cancerTherapeutic targeting of tumor-stroma interactions.Breast cancer stem cells and their role in resistance to endocrine therapy.Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies.Pro-metastatic tumor-stroma interactions in breast cancer.Advances in mechanisms of resistance to aromatase inhibitors.Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns.Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells.Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer.c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis.Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.Enhanced ZnR/GPR39 Activity in Breast Cancer, an Alternative Trigger of Signaling Leading to Cell Growth.
P2860
Q33789414-E13D4C8D-E83C-4603-8F87-8ED24360025EQ34105995-DB551CA3-D31E-4F82-89F1-0481BBC92D43Q34857146-2C8B86CD-3BE7-49B3-9EA1-2DC87BB2F3DDQ35113027-7BEB316E-871E-42EA-B7DF-45EDC5749D15Q35750448-DB249CFD-9B23-4754-8078-EC4B2A776CB1Q35832949-A02CB469-D5E2-4489-AF57-515C389BA0E8Q35995710-2E8CFB42-53F5-4DEB-B8F8-0390CEFEEA8FQ36263003-FB424D49-8C4C-4C3D-9A6A-00F4B491740FQ36956729-849002C9-BD91-4DDB-83B3-6CDD6B67E239Q36983136-CC1385C8-3A1B-4222-9C86-F8791F96797CQ37131348-D146DEDE-B800-4FFC-9E08-CA1173E41D05Q37167029-0A81CE4F-029C-4DDF-9C79-DE9E0FAFF621Q37360172-8972F0A4-0423-49E9-9DC8-664BB5B8D390Q37677429-4D585620-126B-4260-847D-34DA0532A2CCQ37771259-5306F3F7-8F8C-404D-8FAA-19B735DDE6AEQ37851151-4D0F54EC-9951-4C62-A997-5DDA04FFDC64Q37901429-9A060C1F-BC21-48B3-9694-00D4E0EBB53AQ37992086-27888751-CC8F-4A31-97AB-41ADCEC07737Q37992693-64C1E226-ECAF-4C92-8082-A364444A7DD5Q38059502-1C295367-FDFC-4255-BECF-152BDAE023E0Q38190106-D7B8E944-AA5C-45B7-8E41-EDEDDAC8BF19Q38269966-92737BF8-98A6-4147-B06B-47601CD2E440Q39720714-12746FF8-3BB7-4C37-82F8-D709BE363621Q39899689-2F19737C-646C-4940-8E1B-B381C0436685Q44590868-90810F03-D6D1-4E5D-8DA6-5CBEF16EF5D1Q51611913-7103E435-BB2A-43C5-961F-7F5A53259647Q54610139-28772EEB-F150-4ADB-944F-A9DE59FBDA58Q55119860-CE8DC457-A86C-4AA0-AFD6-26D6FC6A9B92
P2860
Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Src kinase promotes adhesion-i ...... resistant breast cancer cells.
@en
type
label
Src kinase promotes adhesion-i ...... resistant breast cancer cells.
@en
prefLabel
Src kinase promotes adhesion-i ...... resistant breast cancer cells.
@en
P2093
P2860
P1476
Src kinase promotes adhesion-i ...... -resistant breast cancer cells
@en
P2093
Nicola J Jordan
Robert I Nicholson
Tim P Green
P2860
P2888
P304
P356
10.1007/S10585-007-9065-Y
P577
2007-03-30T00:00:00Z
P6179
1039019470